Prostate Cancer

Showing NaN - NaN of 180

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)

Not yet recruiting
  • Prostate Cancer
  • ADI-PEG 20
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 16, 2023

Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

Not yet recruiting
  • Prostate Cancer
  • Radical Prostatectomy
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2023

Prostate Cancer Trial in Houston (177Lu rhPSMA-10.1, Degarelix)

Not yet recruiting
  • Prostate Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Men With Prostate Cancer Cared for by "Active Surveillance

Not yet recruiting
  • Prostate Cancer
  • Active Surveillance
  • Houston, Texas
    M D Anderson Cancer Center
Apr 24, 2023

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Prostate Cancer Trial in United States (Relugolix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer
  • Tucson, Arizona
  • +7 more
Feb 1, 2023

Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)

Recruiting
  • Prostate Cancer
  • talazoparib plus enzalutamide
  • Placebo plus enzalutamide
  • Birmingham, Alabama
  • +306 more
Jan 18, 2023

Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)

Active, not recruiting
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
Jan 17, 2023

Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

Active, not recruiting
  • Prostate Cancer
  • High Risk
  • Houston, Texas
    Houston Methodist
Dec 8, 2022

Prostate Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Cabazitaxel)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab
  • +3 more
  • Tucson, Arizona
  • +59 more
Dec 22, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in Canada, United States (Best Systemic Therapy (BST), Best Systemic Therapy (BST) + Surgery or Radiation

Active, not recruiting
  • Prostate Cancer
  • Best Systemic Therapy (BST)
  • +3 more
  • San Francisco, California
  • +3 more
Dec 5, 2022

Prostate Cancer Trial in United States (abiraterone acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Jonesboro, Arkansas
  • +204 more
Nov 30, 2022

Prostate Cancer Trial in United States (Apalutamide, LHRH Analogue, Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +68 more
Nov 28, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

Recruiting
  • Ovarian Cancer
  • +4 more
  • New Haven, Connecticut
  • +6 more
Oct 10, 2022

Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)

Recruiting
  • Prostate Cancer Metastatic
  • Prostate Cancer
  • Houston, Texas
  • +2 more
Oct 7, 2022

Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

Completed
  • Prostate Cancer
  • +4 more
  • NY-ESO-1 Plasmid DNA Cancer Vaccine
  • New York, New York
  • +1 more
Oct 3, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Prostate Cancer Trial in Worldwide (enzalutamide, abiraterone acetate, prednisone)

Recruiting
  • Prostate Cancer
  • Anchorage, Alaska
  • +126 more
Aug 23, 2022

Prostate Cancer Trial in Worldwide (Standard of Care)

Recruiting
  • Prostate Cancer
  • Standard of Care
  • Birmingham, Alabama
  • +107 more
Aug 17, 2022